In medtech, invention is rarely the finish line. The more difficult question is whether a breakthrough can work within the realities of care delivery, from physician workflows and hospital economics to patient access and meaningful healthcare outcomes.
In this video interview, Art Butcher, executive vice president and group president of MedSurg and Asia Pacific at Boston Scientific, makes the case for a more holistic approach to innovation. He explains how Boston Scientific evaluates new technologies not only by their clinical promise but by their ability to improve access to care and patient outcomes, reduce total cost of care and streamline procedures.
The conversation also explores systems thinking in action, from StoneSmartTM Solutions for kidney stone management to FARAWATCHTM, which brings together pulsed field ablation and stroke risk reduction for appropriate patients. The takeaway: lasting medtech impact depends on more than advanced devices. It requires solutions designed for the ecosystem around them.
The editorial staff had no role in this post's creation.